Tsori translates from Hebrew into “balm” in English. It is mentioned in Genesis 37:25: “As they sat down to eat their meal, they looked up and saw a caravan of Ishmaelites coming from Gilead. Their ...

For 14 years, scientists have been growing a tree akin to the Judean balsam — the source of the balm of Gilead — but with no modern counterpart. For 14 years, scientists have been growing a ...

Gilead Sciences, Inc. (NASDAQ:GILD), a biopharmaceutical company, discovers, develops and commercializes medicines to address unmet medical needs in the United States, Europe and internationally.

Gilead Sciences has shored up its antibody-drug conjugate pipeline by licensing a candidate from German biotech Tubulis in a deal worth up to $415 million. The agreement includes an upfront ...

After years of demands from shareholders for another major deal, Gilead has made a spectacular move, sealing a deal to acquire cell therapy leader Kite for just under $12 billion. Gilead had been ...

Gilead isn’t the only Big Pharma to take an interest in Tubulis’ ADC tech. BMS paid the company $23 million upfront in April 2023, with over $1 billion in potential milestones, for exclusive ...

The deal with Tubulis will help Gilead regain its footing in the ADC space following the withdrawal of Trodelvy in bladder cancer and its late-stage fail in NSCLC. Gilead Sciences on Tuesday put forth ...

Lemon balm, or Melissa officinalis, supplements are becoming increasingly popular due to the believed health benefits they provide. This plant, which is part of the mint family, is celebrated for ...

-- Gilead and Terray Will Leverage Terray’s tNova Drug Discovery Platform to Identify Small Molecule Therapeutics Against Targets of Interest -- FOSTER CITY, Calif. & LOS ANGELES--(BUSINESS WIRE ...

US biotech Assembly Biosciences (Nasdaq: ASMB) has announced an equity investment of $20.1 million by Gilead Sciences (Nasdaq: GILD) to purchase additional common stock in the company and an amendment ...